AzTrials
AzTrials

Cardiac ArrestNCT02277015

Intubation During Pediatric Resuscitation

A study testing Miller Laryngoscope, The Berci-Kaplan DCI and The AirTraq in people with Cardiac Arrest and Endotracheal Intubation, run by International Institute of Rescue Research and Education at 1 site in Poland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The European Resuscitation Council (ERC) 2010 cardiopulmonary resuscitation (CPR) guidelines suggest that intubators should be able to secure the airway without interrupting chest compression. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
Miller Laryngoscope, The Berci-Kaplan DCI and The AirTraq
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
94 participants
Where
1 sitePoland
Study dates
Oct 2014to Nov 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • give voluntary consent to participate in the study
  • minimum 1 year of work experience in emergency medicine
  • experienced emergency medicine personnel (physicians, nurses, paramedics)

Who cannot join

  • not meet the above criteria
  • wrist or low back diseases

Trial locations and contacts

1 site in 1 country.

Poland1 site
  • International Institute of Rescue Research and Education

    Warsaw, Masovia, 03-122

Other trials in Poland

About this study

Official title: Pediatric Tracheal Intubation Using Four Video-laryngoscopes and the Miller Laryngoscope With and Without Chest Compressions

The European Resuscitation Council (ERC) 2010 cardiopulmonary resuscitation (CPR) guidelines suggest that intubators should be able to secure the airway without interrupting chest compression. We examine the performance of the Berci-Kaplan DCI (BERCI), the GlideScope (GVL), the AirTraq, the Pentax AWS (Pentax) and the Miller laryngoscope (MIL) for endotracheal intubation (ETI) during pediatric resuscitation with and without chest compressions.

Being tested
Miller Laryngoscope, The Berci-Kaplan DCI, The AirTraq, GlideScope GVL, The Pentax AWS
Medical subject headings
Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Miller LaryngoscopeDevice

    Direct Laryngoscopy

  • The Berci-Kaplan DCIDevice

    Videolaryngoscope-1

  • The AirTraqDevice

    Videolaryngoscope-2

  • GlideScope GVLDevice

    Videolaryngoscope-3

  • The Pentax AWSDevice

    Videolaryngoscope-4

Study groups in NCT02277015
Study groupRoleWhat they receive
ETI without chest compressionsExperimentalEndotracheal intubation during pediatric resuscitation without chest compressions.
Receives: Device: Miller Laryngoscope; Device: The Berci-Kaplan DCI; Device: The AirTraq; Device: GlideScope GVL; Device: The Pentax AWS
ETI with chest compressionsExperimentalEndotracheal intubation during pediatric resuscitation with chest compressions. Chest compression was performed using LUCAS-2 (Physio-Control).
Receives: Device: Miller Laryngoscope; Device: The Berci-Kaplan DCI; Device: The AirTraq; Device: GlideScope GVL; Device: The Pentax AWS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intubation Time

    time in seconds required for a successful intubation attempt with the five different ETI devices

    Measured: 1 month

Secondary outcomes (6)
  1. Successful intubation

    effectiveness of first, second, third intubation attempts and overall effectiveness intubation attempt using all intubation devices

    Measured: 1 month

  2. POGO score

    self reported percentage og glottis opening (POGO) score

    Measured: 1 month

  3. VAS score

    To assess subjective opinion about the difficulty of the procedure, participants were asked to rate it on a visual analogue scale (VAS) with a score from 1 (very easy) to 5 (very difficult).

    Measured: 1 month

  4. Preferred ETI device

    participants were asked which method of ETI they would prefer in a real-life resuscitation.

    Measured: 1 month

  5. First Pass Attempt

    Endotracheal Intubation (ETI) attempt will be defined as tip of the laryngoscope blade passing the patient's lips. First attempt success rate will be defined as the number of successful placements occurring on the first attempt to place the endotracheal tube.

    Measured: 1 month

  6. Overall Success

    Overall success rate will be defined as the total number of successful placements divided by the total number of patients treated.

    Measured: intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2014 (estimated)
  2. Study startOct 2014
  3. Primary completionNov 2014
  4. Study completionNov 2014 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
94 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02277015
Sponsor's protocol ID
ETI/2014/02
Status last verified
Oct 2014
First submitted
26 Oct 2014
Last updated
13 Nov 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Miller Laryngoscope, The Berci-Kaplan DCI and The AirTraq in people with Cardiac Arrest and Endotracheal Intubation, run by International Institute of Rescue Research and Education at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Nov 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intubation Time (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in